Besides that, carriers of CYP1B1 4326 GG genotype was also associated with shorter PFS and overall survival (OS) in non-small-cell lung carcinoma (NSCLC) patients treated with docetaxel as compared to carriers of CYP1B1 4326 CC and CG genotypes (Vasile et al., 2015). Here, CYP1B1 is linked to non-small cell lung carcinoma.